LMRI Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 7.59%, SMA50 -5.83%, SMA200 -6.58%). The stock’s 14-day RSI is 50.2 (neutral), while the ATR of 1.23 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -25.81% below its high and over 44.81% above its low. Average 10-day trading volume of 458.30 thousand shares is below the 3-month average of 827.39 thousand, indicating normal recent market interest.

Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ:LMRI) closed at $11.13 USD, gaining $0.03 (0.27%) from the previous close of $11.10. The stock is currently mid-range between its 52-week high and low $6.45 and $19.45. With a market capitalization of about $1.07 billion, Lumexa Imaging Holdings, Inc. Common Stock is classified as a small-cap and shows market-like volatility (beta ~0.99). Key stats such as the average daily volume over the past year has been around 809.93 thousand shares, volume is running light vs its 52-week average. Headquartered in Raleigh, NC, Lumexa Imaging Holdings, Inc. Common Stock operates in the Healthcare sector and the Medical - Devices industry. Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States.

Analyst sentiment is bullish. Analyst rating data shows there are 5 Strong Buy ratings, 2 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $23.00 to $9.00. The high target offers 106.65% upside. The low target suggests -19.14% downside. The mean target is $19.71. This offers 77.09% upside. Lumexa Imaging Holdings, Inc. Common Stock earnings surprise history is a mixed track record. The quarter that ended May 12, 2026, missed forecasts by -83.33%. The prior quarter beat by -1420.0%. Over the last six quarters, Apple has recorded several small beats. These include -1420.0% in March 26, 2026.

Our AI price prediction model suggests that Lumexa Imaging Holdings, Inc. Common Stock stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 12.58%, with price expected at $12.53 by July 31, 2026, within a range of $11.67 to $13.39 3-Month Outlook: Projected fall of -98.2%, reaching $0.20 by October 12, 2026, with a range of $0.00 to $0.46. 1-Year Outlook: Projected loss of -99.19%, with price at $0.09 by July 20, 2027, within a range of $0.00 to $0.27.

currently trading near 52-week highs band. Valuation shows Lumexa Imaging Holdings, Inc. Common Stock trading at a premium to the broader market with a P/E of -30.55. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $19.71, suggesting 77.09% upside. Our AI forecast model points to short-term strength (12.58% over two weeks), a medium-term fall (-98.2% over three months), and a longer-term loss (-99.19% over one year), with expected trading ranges indicating moderate volatility.

Lumexa Imaging Holdings, Inc. Common Stock last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$11.37. This means the shares are trading below this model’s fair value.

Lumexa Imaging Holdings, Inc. Common Stock trades at a P/E ratio of -30.55, slightly below the S&P 500 average, with a price-to-sales ratio of 2.04 and a price-to-book ratio of 1.77 suggesting the stock is closer to book value. The P/FCF stands at 101.5, also above market averages.